Triventures

About The Fund

Triventures is a global multi-stage venture capital fund focused on the intersection of health and technology, with a particular emphasis on bio-convergence and data-driven technologies. They aim to invest in early-stage companies that have validated business models capable of industry transformation. The fund's investment strategy targets startups that are innovating in sectors like genomics, e-commerce health services, wellness, robotics, decision support, cyber security specifically tailored for healthcare, and disruptive medical devices and diagnostics. They have a strategic presence in the US, Israel, and Canada, which provides them with a strong network to support portfolio companies and foster cross-industry growth. Triventures is interested in funding opportunities that create substantial impacts on the quality and cost of healthcare through cross-sector plays. They are not interested in incremental changes but instead focus on data-driven healthcare solutions that can meaningfully improve care. With specific capital deployment ranging from $1 million to $5 million, with a sweet spot of around $3 million, they demonstrate versatility in financing stages, including Early, Seed, and Series A rounds. Their fund manages assets totaling $100 million, reflecting a significant capacity for investment and support of portfolio startups. By leveraging their comprehensive healthcare expertise, they seek to drive innovation not just in healthcare but across multiple industries that can be redefined through the application of advanced health-based technologies. Investments span a diverse range of sectors, including IT, Education, BioTech, Business Solutions, Hardware, A.I., Blockchain, Web Security, Analytics, Cloud Services, GovTech, Material Science, Medical Devices, Messaging, Payments, Healthcare, Investment Management, Life Science, and Oncology.